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TO THE EDITOR, 
 
Frontal fibrosing alopecia (FFA) is a predominantly postmenopausal, primary lymphocytic 
cicatricial alopecia (Kossard, 1994), thought to be a clinical subvariant of lichen planopilaris 
(Kossard et al., 1997). Somewhat of a misnomer, the descriptor FFA remains widely used for 
what is a generalized cutaneous lichenoid and fibrosing disorder, invariably associated with 
widespread body hair loss (Chew et al., 2010), extending beyond the frontovertex, especially 
if untreated (Figure 1a). Histopathologically, FFA features peri-isthmic lymphocytes (Figure 
1b), and immune privilege collapse at the bulge may underpin inflammation-driven 
epithelial hair follicle stem cell loss and scarring (Tziotzios et al., 2016).  
MicroRNAs (miRNAs) are small, non-coding ribonucleic acid molecules (RNAs) that 
may impact protean biological functions (Lau et al., 2001). They have emerged as potential 
candidates of pathobiologic, diagnostic and therapeutic interest in chronic inflammatory, 
fibrotic and autoimmune diseases (Hwang et al., 2006; Galasso et al., 2010; Zhang and 
Farwell, 2008; Pauley et al., 2009; Patel and Noureddine, 2012). MicroRNAs can be detected 
in plasma, wherein they circulate in a stable form (Yang et al., 2015; Gilad et al., 2008; Chen 
et al., 2008; Mitchell et al., 2008; 2008; Valadi et al., 2007; Guo et al., 2017). We sought to 
characterize miRNAs in FFA and probe disease relevance by undertaking tissue and 
circulating miRNA co-expression analysis in FFA cases vs matched controls. Neither deep 
transcriptomic analysis nor miRNA signature exploration has previously been explored for 
their bearing in FFA, to our knowledge.  
Seven newly-diagnosed, treatment-naïve FFA cases and seven matched controls 
were ascertained for tissue miRNA analysis (Table S1). After written informed consent and 
institutional ethics approval, temporal scalp skin biopsy was obtained from cases and 
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controls. Each case was evaluated clinically and histologically to confirm active disease. Part 
of each biopsy was immediately immersed in RNAlater; total RNA was isolated using RNeasy 
Plus Universal kit (Qiagen, Valencia, USA) and miRNAs retained according to the 
manufacturer’s protocol (see Supplementary section). All samples underwent microarray 
analysis on Affymetrix GeneChip miRNA 4.0 arrays. Next, to explore whether circulating 
miRNAs pertinent to fibrosis are relevant to FFA pathogenesis, venous blood was obtained 
from a separate cohort of 10 biopsy-proven treatment-naïve FFA cases and 10 matched 
controls (Table S2). Plasma was isolated by centrifuging blood at 2,000g for 20 minutes at 
4
o
C and stored at -80
o
C until analysis. MicroRNAs were isolated using Qiagen miRNeasy 
Serum/Plasma Kit, according to the manufacturer’s protocol. Expression analysis was 
undertaken using the Human Fibrosis miRNA PCR Array (Qiagen) (see Supplementary 
section). 
We first constructed a co-expression network of tissue miRNAs to investigate their 
molecular importance in FFA. The network was generated by assessing pairwise similarity of 
miRNAs expressed in each group (controls and FFA), calculated by the Pearson correlation 
coefficient (PCC) (see Supplementary section and Figure 2a). A co-expression network 
establishes an association among miRNAs that demonstrate a coordinated expression 
pattern across a group of samples. It has been postulated that conserved co-expression 
confers a selective advantage and therefore such genes might be functionally related (Piro 
et al., 2011; Stuart et al. 2003); such networks can therefore provide insight into how cells 
accomplish their functions. Only miRNA pairs that correlated above the 0.95 PCC threshold 
value were represented for each tissue network to capture the strongest relationship for 
miRNA expression regulation. The resulting FFA network displayed 2,089 co-expressed 
miRNAs (nodes) with 3,009 non-duplicate interactions (edges), while for controls there were 
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2,100 co-expressed miRNAs (nodes) with 2,934 non-duplicate interactions (edges). Both 
tissue networks were used as molecular reference datasets to identify communities of 
miRNAs sharing common functions. For this analysis, we used the Affinity Propagation 
Clustering algorithm (see Supplementary section). We generated a list of communities for 
the two tissue networks and automatically identified cluster centers (exemplars) as 
representative miRNAs of each community (Table S4).  
Next, differential expression analysis was applied in the plasma dataset to calculate 
the changes in expression between control and FFA samples and to identify up- or down-
regulated circulating miRNAs (Figures 2b and S1). Fifty-five miRNAs were found to be up-
regulated in FFA while 11 miRNAs were down-regulated.  For those circulating miRNAs, we 
further tested: (i) their predictive value; and (ii) if any of them mapped within the 
communities of tissue networks. To evaluate their predictive value, we used Random Forest 
with CARET package in R, which ranks all data elements representing the most influential 
predictors (Table S5 and Figure S2). To further evaluate circulating miRNAs that were found 
to be differentially expressed between controls and cases, we mapped them within the 
tissue-specific co-expression networks. Twenty exemplars in the control tissue miRNA 
network were significantly enriched in the plasma dataset compared to 27 exemplars, which 
were significantly enriched in the FFA tissue miRNA network. Amongst these exemplars, 
there were 17 miRNAs common in both networks (cases and controls): three of these were 
specific to controls whilst nine were representative of FFA. Of those nine circulating miRNAs, 
four were found to be highly predictive of disease status. Those miRNAs were, in order of 
importance, hsa-let-7d-5p, hsa-miR-18a-5p, has-miR-20a-5p and hsa-miR-19a-3p, which are 
also co-targeting similar sets of genes. While the latter three are part of the same cluster, 
hsa-let-7d-5p is independent of the cluster (Figure 2c) and the commonality in co-targeting 
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similar genes is of particular interest. As previously suggested, if different miRNAs co-target 
similar sets of genes, these might regulate the same functions (Tsang et al., 2010; Su et al., 
2011). We applied GAGE analysis to infer pathways associated with FFA and found MAPK 
signaling, Endocytosis and Focal Adhesion pathways to be down-regulated and enriched in 
the networks of co-targeting genes across these four miRNAs (Table S6). 
Our study identified circulating miRNAs hsa-let-7d-5p, hsa-miR-18a-5p, has-miR-20a-
5p and hsa-miR-19a-3p as being highly predictive of disease status in FFA by using a skin-
specific miRNA network as a validating molecular mapping dataset. Functional validation is 
needed in future to determine mechanistic relevance, while any additional circulating 
miRNAs that did not map to the skin network, despite having been found to be predictive in 
our analysis of plasma, could be further explored in larger cohorts. 
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Figure legends 
 
Figure 1. Clinical and histologic features of FFA. (a) Scarring alopecia with frontal and 
marginal scalp involvement as well as eyebrow loss; (b) Horizontal section of the isthmic 
area showing perifollicular fibrosis, follicular tufting, and a moderately dense perifollicular 
lymphoid cell infiltrate. A fragment of a naked hair shaft is also seen. (Hematoxylin-eosin 
stain; scale bar=75 µm). Patient permission to publish these clinical photographs has been 
received. 
 
Figure 2. Circulating miRNAs within tissue-specific co-expression network establishes 
evident differences between FFA and controls. (a) miRNA expression matrix displays the 
expression values of the two different phenotypes: FFA (gray color) and Controls (white 
color) in relation to different miRNAs in tissue-specific dataset. Pairwise similarity in miRNA 
expression vectors was expressed by the Pearson Correlation Coefficient (PCC). Nodes 
correspond to miRNAs while edges correspond to the pairwise expression similarity. Tissue 
co-expression networks in control (left) and FFA (right) were generated. Communities of 
miRNAs were further detected in the two networks after applying APCluster algorithm.  (b) 
Plasma-specific expression profiles used to identify differentially expressed circulating 
miRNAs in the skin of patients with FFA, compared to controls. Plasma-specific miRNA 
signature was further mapped into the cluster centers identified in the two networks after 
applying APCluster algorithm. Over-expressed miRNAs are colored red while under-
expressed miRNAs are depicted in green; (c) Predicted circulating miRNAs co-targeting 
similar sets of genes. 
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